Docking analysis identifies high-efficacy binding interactions in a human cannabinoid receptor, suggesting therapeutic potential.
The amino acid residue His178 mediates high-efficacy agonism (as seen with HU-210) but exhibits limited accessibility. Docking analysis of the test structure revealed a unique interaction network involving His178, Met109, and the K376 within the deep binding pocket:
No takes yet. Share an insight, caveat, or question.
Yaroslav Zaitsev (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: